<DOC>
	<DOCNO>NCT00330369</DOCNO>
	<brief_summary>This research study new experimental drug call darusentan . Darusentan currently approve U.S. Food Drug Administration ( FDA ) use United States , mean doctor prescribe drug . The purpose study determine darusentan effective reduce systolic blood pressure subject resistant systolic hypertension , despite treatment full dos three antihypertensive drug , include diuretic .</brief_summary>
	<brief_title>DORADO - Fixed Doses Darusentan Compared Placebo Resistant Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>LU 135252</mesh_term>
	<criteria>Subjects competent provide write consent Aged 35 80 year Subjects diabetes and/or chronic kidney disease must mean systolic blood pressure ≥130 mmHg All subject must mean systolic blood pressure ≥140 mmHg Receiving adhere full dos appropriate guidelinerecommended antihypertensive drug three different class antihypertensive agent , include diuretic Female subject nonchildbearing potential ( i.e. , postmenopausal l 2 year ; surgically sterile ) Average sit systolic blood pressure ≥180 mmHg diastolic blood pressure ≥110 mmHg Serum ALT AST &gt; 2 x upper limit normal range ( ULN ) Subjects experienced myocardial infarction , unstable angina pectoris , cerebrovascular accident ( CVA ) within 6 month ; sick sinus syndrome second third degree atrioventricular block , atrial fibrillation recurrent atrial tachyarrhythmia , recurrent ventricular tachycardia , symptomatic bradycardia Implanted pacemaker implant cardioverter defibrillator ( ICD ) Symptomatic congestive heart failure require treatment Hemodynamically significant valvular heart disease Type I diabetes mellitus Hemodialysis peritoneal dialysis ; history renal transplant Diagnosis recurrence malignancy within past 3 year Sleep apnea , unless recent sleep study demonstrate arterial oxygen saturation great equal 90 % Subjects perform alternate shift night work Subjects participate clinical study involve another investigational drug device within 4 week prior Screening</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>